Increased Serum Cathepsin K in Patients with Coronary Artery Disease

키워드

참고문헌 (44)

1. Turk V, "Lysosomal cysteine proteases: facts and opportunities", EMBO J, 20, pp.4629~4633 (2001)
2. Cheng XW, "Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication", Circulation, 125, pp.1551~1562 (2012)
3. Cheng XW, "Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications", Hypertension, 58, pp.978~986 (2011)
4. Reiser J, "Specialized roles for cysteine cathepsins in health and disease", J Clin Invest, 120, pp.3421~3431 (2010)
5. Sukhova GK, "Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells", J Clin Invest, 102, pp.576~583 (1998)
6. Shi GP, "Cystatin C deficiency in human atherosclerosis and aortic aneurysms", J Clin Invest, 104, pp.1191~1197 (1999)
7. Cheng XW, "Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries", Am J Pathol, 164, pp.243~251 (2004)
8. Burns-Kurtis CL, "Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit", Cardiovasc Res, 62, pp.610~620 (2004)
9. Sun M, "Cathepsin-L contributes to cardiac repair and remodelling post-infarction", Cardiovasc Res, 89, pp.374~383 (2011)
10. Sun J, "Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice", Arterioscler Thromb Vasc Biol, 31, pp.2500~2508 (2011)
11. Sun J, "Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice", Arterioscler Thromb Vasc Biol, 32, pp.15~23 (2012)
12. Cheng XW, "Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment", Am J Pathol, 173, pp.358~369 (2008)
13. Li Z, "Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates", Biochemistry, 39, pp.529~536 (2000)
14. Novinec M, "Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors", J Biol Chem, 282, pp.7893~7902 (2007)
15. Liu J, "Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells", Atherosclerosis, 184, pp.302~311 (2006)
16. Cheng XW, "Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3", Am J Pathol, 168, pp.685~694 (2006)
17. Lutgens SP, "Cathepsin cysteine proteases in cardiovascular disease", FASEB J, 21, pp.3029~3041 (2007)
18. Lutgens E, "Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation", Circulation, 113, pp.98~107 (2006)
19. Hua Y, "Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy", Hypertension, 61, pp.1184~1192 (2013)
20. Hua Y, "Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction", Diabetes, 62, pp.498~509 (2013)
21. Cheng XW, "Elastolytic cathepsin induction", activation system exists in myocardium and is upregulated in hypertensive heart failure, 2006, pp.48, 979~987
22. Smith ER, "Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease", Hypertension, 59, pp.973~978 (2012)
23. Liu J, "Increased serum cathepsin S in patients with atherosclerosis and diabetes", Atherosclerosis, 186, pp.411~419 (2006)
24. Thygesen K, "Third universal definition of myocardial infarction", Eur Heart, 33, pp.2551~2567 (2012)
25. Mintz GS, "American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents", J Am Coll Cardiol, 37, pp.1478~1492 (2001)
26. Libby P, "Mechanisms of acute coronary syndromes", N Engl J Med, 369, pp.883~884 (2013)
27. Libby P, "Immune effector mechanisms implicated in atherosclerosis: from mice to humans", Immunity, 38, pp.1092~1104 (2013)
28. Xiang Li, "Cysteinyl Cathepsins: Multifunctional Enzymes in Cardiovascular Disease", 전남의대학술지, 48(2), pp.77~85 (2012), 의과학연구소
29. Zografos TA, "Serum cathepsin levels in coronary artery ectasia", Int J Cardiol, 145, pp.606~607 (2010)
30. Liu Y, "Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease", Am J Cardiol, 103, pp.476~481 (2009)
31. Chatzizisis YS, "Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs", Circulation, 123, pp.621~630 (2011)
32. Platt MO, "Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis", Am J Physiol Heart Circ Physiol, 292, pp.H1479~H1486 (2007)
33. Libby P, "Mechanisms of acute coronary syndromes and their implications for therapy", N Engl J Med, 368, pp.2004~2013 (2013)
34. Nakamura K, "Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation", Atherosclerosis, 206, pp.355~361 (2009)
35. Hermus L, "Carotid plaque formation and serum biomarkers", Atherosclerosis, 213, pp.21~29 (2010)
36. Geluk CA, "C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort", Atherosclerosis, 196, pp.372~382 (2008)
37. Liang J, "Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits", Circulation, 113, pp.1993~2001 (2006)
38. Libby P, "Inflammation and atherosclerosis", Circulation, 105, pp.1135~1143 (2002)
39. Sukhova GK, "Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice", J Clin Invest, 111, pp.897~906 (2003)
40. Sasaki T, "AT1 blockade attenuates atherosclerotic plaque destabilization accompanied by the suppression of cathepsin S activity in apoE-deficient mice", Atherosclerosis, 210, pp.430~437 (2010)
41. Schwartz SM, "Plaque rupture in humans and mice", Arterioscler Thromb Vasc Biol, 27, pp.705~713 (2007)
42. Fukuda D, "Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris", Am J Cardiol, 97, pp.175~180 (2006)
43. Oörni K, "Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro", J Biol Chem, 279, pp.34776~34784 (2004)
44. Lindstedt L, "Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells", Biochem Biophys Res Commun, 312, pp.1019~1024 (2003)

관련 논문AI추천